(Q28139932)

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Stable complexes involving acetylcholinesterase and amyloid-beta peptide change the biochemical properties of the enzyme and increase the neurotoxicity of Alzheimer's fibrils.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Do nonsteroidal anti-inflammatory drugs decrease the risk for Alzheimer's disease?: The Rotterdam Study

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Scavenging of Alzheimer's amyloid beta-protein by microglia in culture.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

A comparison of β-amyloid (Aβ) deposition in the medial temporal lobe in late-onset sporadic Alzheimer's disease, and Down's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Dramatic aggregation of Alzheimer abeta by Cu(II) is induced by conditions representing physiological acidosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Vitamin E protects nerve cells from amyloid beta protein toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Hydrogen peroxide mediates amyloid beta protein toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Amyloid beta peptide induces necrosis rather than apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

17-beta estradiol protects neurons from oxidative stress-induced cell death in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Neuroprotection against oxidative stress by estrogens: structure-activity relationship

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Alzheimer's disease and oxidative stress: implications for novel therapeutic approaches

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Antioxidant properties of melatonin--an emerging mystery

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Alpha-2 macroglobulin is genetically associated with Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Microglial-produced nitric oxide and reactive nitrogen oxides mediate neuronal cell death

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Nuclear translocation of NF-kappaB in cholinergic neurons of patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Promotion of transition metal-induced reactive oxygen species formation by beta-amyloid

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Estrogen protects neuronal cells from the cytotoxicity induced by acetylcholinesterase-amyloid complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Age-dependent impairment of mitochondrial function in primate brain

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

The amyloid beta protein induces oxidative damage of mitochondrial DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

The 21-aminosteroid inhibitors of lipid peroxidation: reactions with lipid peroxyl and phenoxy radicals

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Monozygotic twins with Alzheimer's disease treated with melatonin: Case report

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Oxidatively induced structural alteration of glutamine synthetase assessed by analysis of spin label incorporation kinetics: relevance to Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Relationships between neuronal death and the cellular redox status. Focus on the developing nervous system.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Impairment in mitochondrial cytochrome oxidase gene expression in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Decreased expression of nuclear and mitochondrial DNA-encoded genes of oxidative phosphorylation in association neocortex in Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Production of superoxide anions by a CNS macrophage, the microglia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Induction of superoxide anion and nitric oxide production in cultured microglia.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Regional distribution of iron and iron-regulatory proteins in the brain in aging and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Oxidative metabolism in cultured fibroblasts derived from sporadic Alzheimer's disease (AD) patients

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Melatonin prevents beta-amyloid-induced lipid peroxidation

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

beta-amyloid activates the O-2 forming NADPH oxidase in microglia, monocytes, and neutrophils. A possible inflammatory mechanism of neuronal damage in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Amyloid beta peptides do not form peptide-derived free radicals spontaneously, but can enhance metal-catalyzed oxidation of hydroxylamines to nitroxides

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Positron emission tomography in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Scavenger receptor-mediated adhesion of microglia to beta-amyloid fibrils

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

No effect of anti-leprosy drugs in the prevention of Alzheimer's disease and beta-amyloid neurotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Reduced mortality associated with long-term postmenopausal estrogen therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Increased nuclear DNA oxidation in the brain in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

In vitro peroxidase oxidation induces stable dimers of beta-amyloid (1-42) through dityrosine bridge formation

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Altered brain metabolism of iron as a cause of neurodegenerative diseases?

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

The incidence of dementia and intake of animal products: preliminary findings from the Adventist Health Study

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Ameboid microglia as effectors of inflammation in the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Selective accumulation of aluminum and iron in the neurofibrillary tangles of Alzheimer's disease: a laser microprobe (LAMMA) study

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Nordihydroguaiaretic acid protects hippocampal neurons against amyloid beta-peptide toxicity, and attenuates free radical and calcium accumulation

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid beta-peptide toxicity in hippocampal neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Decreased catalase activity but unchanged superoxide dismutase activity in brains of patients with dementia of Alzheimer type.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Alzheimer's presenilin mutation sensitizes neural cells to apoptosis induced by trophic factor withdrawal and amyloid beta-peptide: involvement of calcium and oxyradicals.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Presenilins: genes for life and death

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

The presenilins in Alzheimer's disease--proteolysis holds the key.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Sex differences in postischemic neuronal necrosis in gerbils

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Lipid peroxidation, oxygen radicals, cell damage, and antioxidant therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

A hypothesis on the pathogenesis of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Alzheimer's disease. A glycation connection.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Brain Regional Correspondence Between Alzheimer's Disease Histopathology and Biomarkers of Protein Oxidation

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Expression of DNA excision-repair-cross-complementing proteins p80 and p89 in brain of patients with Down Syndrome and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Bcl-2 functions in an antioxidant pathway to prevent apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Glucose metabolism as the site of the primary abnormality in early-onset dementia of Alzheimer type?

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

The Aβ Peptide of Alzheimer's Disease Directly Produces Hydrogen Peroxide through Metal Ion Reduction†

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Cu(II) potentiation of alzheimer abeta neurotoxicity. Correlation with cell-free hydrogen peroxide production and metal reduction.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Leukocytic oxygen activation and microbicidal oxidative toxins

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Cellular and molecular basis of estrogen's neuroprotection. Potential relevance for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Presence of T-cytotoxic suppressor and leucocyte common antigen positive cells in Alzheimer's disease brain tissue.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Lipid peroxidation and free radical scavengers in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Reversals of age-related declines in neuronal signal transduction, cognitive, and motor behavioral deficits with blueberry, spinach, or strawberry dietary supplementation.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Brain samples from Alzheimer's patients have elevated levels of loosely bound iron

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Reduced glucose transporter at the blood-brain barrier and in cerebral cortex in Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Transcription factor NF-kappaB is activated in primary neurons by amyloid beta peptides and in neurons surrounding early plaques from patients with Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Genetic association of the low-density lipoprotein receptor-related protein gene (LRP), and apolipoprotein E receptor, with late-onset Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Impairment of glucose and glutamate transport and induction of mitochondrial oxidative stress and dysfunction in synaptosomes by amyloid beta-peptide: role of the lipid peroxidation product 4-hydroxynonenal

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

17Beta-estradiol attenuates oxidative impairment of synaptic Na+/K+-ATPase activity, glucose transport, and glutamate transport induced by amyloid beta-peptide and iron

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Amyloid beta-peptide disrupts carbachol-induced muscarinic cholinergic signal transduction in cortical neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Alteration of transcription factors NF-kappaB and STAT1 in Alzheimer's disease brains

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Activation of macrophages by Alzheimer beta amyloid peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Cell surface APP751 forms complexes with protease nexin 2 ligands and is internalized via the low density lipoprotein receptor-related protein (LRP).

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Vitamin E protects against Alzheimer's amyloid peptide (25-35)-induced changes in neocortical synaptosomal membrane lipid structure and composition

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Evidence that 4-hydroxynonenal mediates oxidative stress-induced neuronal apoptosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Illustration of analysis taking into account complex survey considerations: the association between wine consumption and dementia in the PAQUID study. Personnes Ages Quid.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

N-acetyl-serotonin (normelatonin) and melatonin protect neurons against oxidative challenges and suppress the activity of the transcription factor NF-kappaB.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Detection of point mutations in codon 331 of mitochondrial NADH dehydrogenase subunit 2 in Alzheimer's brains

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Beta amyloid toxicity does not require RAGE protein

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Decreased Melatonin Levels in Postmortem Cerebrospinal Fluid in Relation to Aging, Alzheimer's Disease, and Apolipoprotein E- 4/4 Genotype

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Apoptosis is induced by beta-amyloid in cultured central nervous system neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Elevated 4-hydroxynonenal in ventricular fluid in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Copper, iron and zinc in Alzheimer's disease senile plaques

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Increased DNA oxidation and decreased levels of repair products in Alzheimer's disease ventricular CSF.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Aluminum, iron, and zinc ions promote aggregation of physiological concentrations of beta-amyloid peptide.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Increased peroxidation and reduced antioxidant enzyme activity in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Amyloid beta-peptide impairs ion-motive ATPase activities: evidence for a role in loss of neuronal Ca2+ homeostasis and cell death

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Characterization of 8-epiprostaglandin F2alpha as a marker of amyloid beta-peptide-induced oxidative damage

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Increased cerebral glucose-6-phosphate dehydrogenase activity in Alzheimer's disease may reflect oxidative stress

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Cellular actions of beta-amyloid precursor protein and its soluble and fibrillogenic derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Activation of NF-kappaB protects hippocampal neurons against oxidative stress-induced apoptosis: evidence for induction of manganese superoxide dismutase and suppression of peroxynitrite production and protein tyrosine nitration

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Loss of intraventricular fluid melatonin can explain the neuropathology of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Activation of microglial cells by beta-amyloid protein and interferon-gamma.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the histocompatibility glycoprotein HLA-DR.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Anti‐inflammatory agents as a therapeutic approach to Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Oxidative stress and upregulation of mitochondrial biogenesis genes in mitochondrial DNA-depleted HeLa cells

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Stopped-flow investigation of antioxidant activity of estrogens in solution

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

The amyloid precursor protein of Alzheimer's disease in the reduction of copper(II) to copper(I)

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Reactive oxygen species and Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Copper-binding amyloid precursor protein undergoes a site-specific fragmentation in the reduction of hydrogen peroxide

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Advanced glycation endproducts in ageing and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Influence of advanced glycation end-products and AGE-inhibitors on nucleation-dependent polymerization of β-amyloid peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Neurotoxicity of acetylcholinesterase amyloid beta-peptide aggregates is dependent on the type of Abeta peptide and the AChE concentration present in the complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Apolipoprotein E and antioxidants have different mechanisms of inhibiting Alzheimer's beta-amyloid fibril formation in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Exogenous administration of heme oxygenase-1 by gene transfer provides protection against hyperoxia-induced lung injury

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Estrogen replacement therapy and risk of Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Melatonin prevents death of neuroblastoma cells exposed to the Alzheimer amyloid peptide.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Inhibition of Alzheimer beta-fibrillogenesis by melatonin

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Amyloid beta peptide of Alzheimer's disease downregulates Bcl-2 and upregulates bax expression in human neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Microglial cells internalize aggregates of the Alzheimer's disease amyloid beta-protein via a scavenger receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Cytochrome c oxidase in Alzheimer's disease brain: purification and characterization

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Morphologic association between microglia and senile plaque amyloid in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Nuclear factor-kappa B contributes to excitotoxin-induced apoptosis in rat striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Melatonin in relation to cellular antioxidative defense mechanisms.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Oxidative damage in the central nervous system: protection by melatonin

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Nonsteroidal anti-inflammatory drugs in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Free radicals in the genesis of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Complement activation by beta-amyloid in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Clinical trial of indomethacin in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Translation of the alzheimer amyloid precursor protein mRNA is up-regulated by interleukin-1 through 5'-untranslated region sequences.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Acute phase proteins are present in amorphous plaques in the cerebral but not in the cerebellar cortex of patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Cysteine 144 is a key residue in the copper reduction by the beta-amyloid precursor protein

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Secreted form of amyloid beta protein precursor is involved in the growth regulation of fibroblasts.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Redox metals and neurodegenerative disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Amyloid peptides are toxic via a common oxidative mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Amyloid beta-protein and the genetics of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

The cell biology of beta-amyloid precursor protein and presenilin in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Amyloid beta protein (A beta) removal by neuroglial cells in culture

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Inhibition of PC12 cell redox activity is a specific, early indicator of the mechanism of beta-amyloid-mediated cell death

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Oxidative damage in Alzheimer's

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Widespread peroxynitrite-mediated damage in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Amyloid-β Deposition in Alzheimer Transgenic Mice Is Associated with Oxidative Stress

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Melatonin alters the metabolism of the beta-amyloid precursor protein in the neuroendocrine cell line PC12.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

The alpha-helical to beta-strand transition in the amino-terminal fragment of the amyloid beta-peptide modulates amyloid formation

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Beta-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: implications for Alzheimer's therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Metal ion-catalyzed oxidation of proteins: biochemical mechanism and biological consequences

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Estrogens as natural antioxidants of membrane phospholipid peroxidation

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Is amyloid beta-protein glycated in Alzheimer's disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Regional difference in induction of heme oxygenase-1 protein following rat transient forebrain ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Immunohistochemical localization of redox factor-1 (Ref-1) in Alzheimer's hippocampus

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

beta-Amyloid-mediated vasoactivity and vascular endothelial damage.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Concentrations of serotonin and its related substances in the cerebrospinal fluid in patients with Alzheimer type dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Rifampicin prevents the aggregation and neurotoxicity of amyloid beta protein in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Inhibition of amyloid beta protein aggregation and neurotoxicity by rifampicin. Its possible function as a hydroxyl radical scavenger.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

The cause of neuronal degeneration in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Advanced glycation end products contribute to amyloidosis in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

The Alzheimer's disease amyloid precursor protein modulates copper-induced toxicity and oxidative stress in primary neuronal cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Immunohistochemical study of the beta-chemokine receptors CCR3 and CCR5 and their ligands in normal and Alzheimer's disease brains

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Estrogen reduces neuronal generation of Alzheimer beta-amyloid peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Protective effects of idebenone and alpha-tocopherol on beta-amyloid-(1-42)-induced learning and memory deficits in rats: implication of oxidative stress in beta-amyloid-induced neurotoxicity in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Mechanisms of neuronal degeneration in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Superoxide dismutase activity in Alzheimer's disease: possible mechanism for paired helical filament formation

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Amyloid beta-mediated oxidative and metabolic stress in rat cortical neurons: no direct evidence for a role for H2O2 generation

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021

Glycoprotein 330/megalin: probable role in receptor-mediated transport of apolipoprotein J alone and in a complex with Alzheimer disease amyloid beta at the blood-brain and blood-cerebrospinal fluid barriers

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2800%2900015-0

7 January 2021